Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 14/20 | 0.52 |
| ▸ | MMP13 | P45452 | 12/20 | 0.52 |
| ▸ | MMP1 | P03956 | 10/20 | 0.52 |
| ▸ | MMP9 | P14780 | 7/20 | 0.44 |
| ▸ | MMP14 | P50281 | 4/20 | 0.44 |
| ▸ | MMP8 | P22894 | 2/20 | 0.44 |
| ▸ | MMP3 | P08254 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8000461 | 0.76 | MMP9 (0.54) | MMP2MMP13MMP1MMP9MMP8 | |
| SCHEMBL8002344 | 0.75 | MMP2 (0.51) | MMP2MMP13MMP1MMP9MMP8 | |
| SCHEMBL8005756 | 0.74 | MMP2 (0.50) | MMP2MMP13MMP1MMP9MMP14 | |
| SCHEMBL7365907 | 0.72 | MMP2 (0.48) | MMP2MMP13MMP1MMP9MMP14 | |
| SCHEMBL7539100 | 0.71 | MMP2 (0.50) | MMP2MMP13MMP1MMP9MMP14 | |
| SCHEMBL7998658 | 0.71 | MMP2 (0.54) | MMP2MMP13MMP1MMP9MMP14 | |
| SCHEMBL8002779 | 0.71 | MMP2 (0.51) | MMP2MMP13MMP1MMP9 | |
| SCHEMBL7998659 | 0.69 | MMP2 (0.57) | MMP2MMP13MMP1MMP9 | |
| SCHEMBL6769491 | 0.69 | MMP13 (0.77) | MMP2MMP13MMP1 | |
| SCHEMBL6767568 | 0.69 | MMP13 (0.77) | MMP2MMP13MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6294573-B1 | FOR THERAPY RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPENIAS SUCH AS OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL, EPIDERMAL OR GASTRIC ULCERATION, AND TUMOR GROWTH AND METASTASIS OR INVASION | ABBOTT LABORATORIES | 2001-09-25 | — | — | US | claimed |
| US-6294573-B1 | FOR THERAPY RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPENIAS SUCH AS OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL, EPIDERMAL OR GASTRIC ULCERATION, AND TUMOR GROWTH AND METASTASIS OR INVASION | ABBOTT LABORATORIES | 2001-09-25 | — | — | US | disclosed |